For the eleventh year running, Endocrine News talks to editors from Endocrine Society publications to unearth the most impressive breakthroughs in endocrine science and research for 2025. From GLP-1s, adrenal treatments, and acromegaly breakthroughs to obesity, diabetes, and cutting-edge research in reproductive medicine, 2025 was a banner year for endocrine research and researchers! For more...
How Endocrine Society Journals Continue to Adhere to Maintain the Highest Standards Possible Scientific journal integrity is increasingly being threatened with the rise of predatory journals, fraudulent papers, and even nonsensical submissions. On January 28 this year the Endocrine Society released a statement warning members against solicitations from a journal called “Journal of Endocrinology and...
Another year at the Endocrine Society has drawn to a close. I’m always impressed – and somewhat amazed – by the sheer volume of activities, resources, and advocacy that our organization produces over a 12-month period. I’d like to recap some highlights from 2025! Meetings: Making Connections Between Members and Ideas Meetings lie at the...
Early-career Endocrine Society member and dental student TyShawn Harris became fascinated with endocrinology after working with Stanley Andrisse, PhD, in his laboratory at Howard University. He talks to Endocrine News about his ongoing research and the remarkable connection between endocrinology, diabetes, and dentistry. When TyShawn Harris began dental school at Howard University, he never expected...
The Endocrine Society and The European Society of Endocrinology (ESE) are delighted to announce Anna Gloyn, DPhil, FMedSci, as the winner of the fifth annual Transatlantic Alliance Award. The Transatlantic Alliance Award, launched in 2022, recognizes an international leader who has made significant advancements in endocrine research on both sides of the Atlantic — in Europe and the United States. Gloyn has...
New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged 10-17 years whose diabetes and weight are inadequately controlled with an existing treatment regimen of metformin, insulin, or both. The study (the SURPASS-PEDS trial), led...
Women with persistent thyroid hormone imbalance across pregnancy may be at an increased risk of having children with autism, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Maternal thyroid hormones are essential for fetal neurodevelopment. Gestational thyroid imbalance has been associated with atypical neurodevelopment, including increased risk of autism spectrum disorder (ASD). Autism is...
Omodamola Aje, MD, has built a social media platform to provide women with the tools they need to ask their doctors informed questions and help guide decisions in their treatment, from menopause to hypothyroidism. Aje is using her platform to not only help build a sense of community, but to cut through the rampant misinformation...
Another year at the Endocrine Society has drawn to a close. I’m always impressed – and somewhat amazed – by the sheer volume of activities, resources, and advocacy that our organization produces over a 12-month period. I’d like to recap some highlights from 2025! Meetings: Making Connections Between Members and Ideas Meetings lie at the...
The Endocrine Society and The European Society of Endocrinology (ESE) are delighted to announce Anna Gloyn, DPhil, FMedSci, as the winner of the fifth annual Transatlantic Alliance Award. The Transatlantic Alliance Award, launched in 2022, recognizes an international leader who has made significant advancements in endocrine research on both sides of the Atlantic — in Europe and the United States. Gloyn has...
